Moderna (MRNA) is back to pre-earnings levels as the emergence of the omicron variant and its effect flows through to multiple vaccine makers. Booster
Moderna (MRNA) is back to pre-earnings levels as the emergence of the omicron variant and its effect flows through to multiple vaccine makers. Booster
